MEREO BIOPHARMA GROUP PLC Proceeds From Issue Of Bonds Notes And Debentures
MEREO BIOPHARMA GROUP PLC (MREO) reported Proceeds From Issue Of Bonds Notes And Debentures of GBP 44.38 million for the 12-month period ending 2020-12-31, per its 20-F filed 2023-03-28.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures · last filed 2023-03-28
| Period end | Proceeds From Issue Of Bonds Notes And Debentures 12 month |
|---|---|
| 2020-12-31 | 44.38M GBP 20-F · filed 2023-03-28 |
| 2016-12-31 | 3.46M GBP 20-F/A · filed 2019-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |